Publications by authors named "Anindya Chatterjee"

Claim this Profile
E
Evaluation of bleeding risk in patients who received pirtobrutinib in the presence or absence of antithrombotic therapy.
Nicole Lamanna, Constantine S Tam, Jennifer A Woyach, Alvaro J Alencar, M Lia Palomba, Anindya Chatterjee

EJHaem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option.
Haeseong Park, Samuel J Klempner, Joseph Chao, Zev A Wainberg, Mariusz Lukanowski, Anindya Chatterjee

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world ramucirumab and immune checkpoint inhibitor sequences in US patients with advanced gastroesophageal cancer.
Astra M Liepa, Zhanglin Lin Cui, Julie K Beyrer, Elizabeth L Hadden, Anindya Chatterjee

Future Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory Analysis of Patients With Gastric/Gastroesophageal Junction Adenocarcinoma With or Without Liver Metastasis From the Phase 3 RAINBOW Study.
Takatsugu Ogata, Yukiya Narita, Zev A Wainberg, Eric Van Cutsem, Kensei Yamaguchi, Anindya Chatterjee

J Gastric Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Molecular Biomarker Testing Patterns and Results for Advanced Gastroesophageal Cancers in the United States.
Rutika Mehta, Astra M Liepa, Shen Zheng, Anindya Chatterjee

Curr Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk thresholds for patients to switch between daily tablets and biweekly infusions in second-line treatment for advanced hepatocellular carcinoma: a patient preference study.
Neehar D Parikh, Allicia Girvan, Joshua Coulter, Jonathon Gable, Jiat Ling Poon, Anindya Chatterjee

BMC Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
Daniel V Catenacci, Joseph Chao, Kei Muro, Salah Eddin Al-Batran, Samuel J Klempner, Anindya Chatterjee

Oncologist· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies.
Wasat Mansoor, Eric J Roeland, Aafia Chaudhry, Astra M Liepa, Ran Wei, Anindya Chatterjee

Oncologist· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Data suggest COVID-19 affected numbers greatly exceeded detected numbers, in four European countries, as per a delayed SEIQR model.
Sankalp Tiwari, C P Vyasarayani, Anindya Chatterjee

Sci Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data suggest COVID-19 affected numbers greatly exceeded detected numbers, in four European countries, as per a delayed SEIQR model.
Sankalp Tiwari, C P Vyasarayani, Anindya Chatterjee

Sci Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New approximations, and policy implications, from a delayed dynamic model of a fast pandemic.
C P Vyasarayani, Anindya Chatterjee

Physica D· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing treatment duration with ramucirumab and paclitaxel by managing chemotherapy-associated toxicity: Review of four cases.
Man Yee Merl, Renee Moye, Anindya Chatterjee, Kenyon D Ogburn

SAGE Open Med Case Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete dimensional collapse in the continuum limit of a delayed SEIQR network model with separable distributed infectivity.
C P Vyasarayani, Anindya Chatterjee

Nonlinear Dyn· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acoustics of Idakkā: An Indian snare drum with definite pitch.
Kevin Jose, Anindya Chatterjee, Anurag Gupta

J Acoust Soc Am· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance.
Joydeep Ghosh, Michihiro Kobayashi, Baskar Ramdas, Anindya Chatterjee, Peilin Ma

J Clin Invest· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder.
Anindya Chatterjee, Joydeep Ghosh, Reuben Kapur

Oncotarget· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A two-state hysteresis model from high-dimensional friction.
Saurabh Biswas, Anindya Chatterjee

R Soc Open Sci· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis.
Anindya Chatterjee, Joydeep Ghosh, Baskar Ramdas, Raghuveer Singh Mali, Holly Martin

Cell Rep· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A reduced-order model from high-dimensional frictional hysteresis.
Saurabh Biswas, Anindya Chatterjee

Proc Math Phys Eng Sci· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pak and Rac GTPases promote oncogenic KIT-induced neoplasms.
Holly Martin, Raghuveer Singh Mali, Peilin Ma, Anindya Chatterjee, Baskar Ramdas

J Clin Invest· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substance dependence treatment interventions: why we continue to fail people who use drugs in Asia.
Mukta Sharma, Anindya Chatterjee

Subst Use Misuse· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT.
Raghuveer Singh Mali, Peilin Ma, Li-Fan Zeng, Holly Martin, Baskar Ramdas, Anindya Chatterjee

Blood· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Partnering with law enforcement to deliver good public health: the experience of the HIV/AIDS Asia regional program.
Mukta Sharma, Anindya Chatterjee

Harm Reduct J· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Class I(A) PI3Kinase regulatory subunit, p85α, mediates mast cell development through regulation of growth and survival related genes.
Subha Krishnan, Raghuveer Singh Mali, Karl R Koehler, Sasidhar Vemula, Anindya Chatterjee

PLoS One· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug users as social change agents in Asia: the diversity of experience and challenges.
Mukta Sharma, Anindya Chatterjee

Subst Use Misuse· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis